CSIMarket
Company Name or Ticker Symbol
Search for oher Categories
 


Biotechnology & Drugs Industry Profitability

Profitability Information & Trends 
  
Select the Industry: Select the Category: Select the Period:

Biotechnology & Drugs Industry Profitability Ratios 1 Q 2017 4 Q 2016 3 Q 2016 2 Q 2016 1 Q 2016
  2017 2016 2016 2016 2016
Gross Margin 81.49 % 82.41 % 79.69 % 68.93 % 71.74 %
Gross Margin Annual (TTM) 82.41 % 82.55 % 80 % 71.35 % 73.1 %
Gross Margin Ranking # 7 # 15 # 9 # 17 # 15
EBITDA Margin 35.42 % 43.57 % 38.52 % - -
EBITDA Margin Annual (TTM) 38.5 % 39.46 % 37.11 % - -
EBITDA Margin Ranking # 12 # 13 # 11 # 99 # 101
Operating Margin 30.56 % 26.11 % 35.01 % - -
Operating Margin Annual (TTM) 31.67 % 34.16 % 34.15 % - -
Operating Margin Ranking # 8 # 20 # 8 # 100 # 99
Pre-Tax Margin 19.46 % 21.95 % 31.71 % - -
Pre-Tax Margin Annual (TTM) 26.27 % 30.32 % 30.8 % - -
Pre-Tax Margin Ranking # 16 # 17 # 5 # 99 # 100
Net Margin 14.07 % 18.9 % 24.68 % - -
Net Margin Annual (TTM) 35.09 % 39.25 % 24.25 % - -
Net Margin Ranking # 17 # 17 # 1 # 99 # 100


Gross Margin Comment

Biotechnology & Drugs Industry's Revenue increased sequentially by 26.39 % faster than Gross Profit increase of 26.39 %, this led to contraction in Gross Margin to 81.49 %, higher than Industry average.

On the trailing twelve months basis gross margin in 1 Q 2017 fell to 82.41 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest gross margin. Gross margin total ranking has deteriorated compare to previous quarter from to 7.

Note, first quarter Numbers include only companies who have reported first quarter earnings results. Numbers change as more businesses report financial results. See the full List.

Gross Margin Statistics
High Average Low
82.41 % 73.99 % 62.16 %
4. quarter 2016   4. quarter 2015

Gross Margin Industry Ranking
Within: No.
Healthcare Sector # 1
Overall # 7

You need to upgrade your Flash Player

Other Gross Margins
Compare Industry's gross margin to Chscl's or S&P Gross profits within Biotechnology & Drugs Industry
Highest Ranking Gross Margins Lowest Ranking Gross Margins
Profitability for Chscl's Suppliers Definiton of Gross Margin

Biotechnology & Drugs Industry EBITDA Margin Statistics

 
You need to upgrade your Flash Player
EBITDA Margin Industry Ranking
Within: No.
Healthcare Sector # 1
Overall # 12
EBITDA Margin Statistics
High Average Low
43.59 % 25.64 % -34.9 %
4. quarter 2016   2. quarter 2016

EBITDA Margin Comment
Biotechnology & Drugs Industry's Revenue increased sequentially by 26.39 % faster than Ebitda increase of -14.79 %, this led to contraction in Ebitda Margin to 35.42 %, higher than Industry average.

On the trailing twelve months basis Ebitda Margin in 1 Q 2017 fell to 38.5 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest ebitda margin. Ebitda margin total ranking has deteriorated compare to previous quarter from to 12.

Other EBITDA Margins
Compare Industry's EBITDA margin to Chscl's or S&P Gross profits within Biotechnology & Drugs Industry
Highest Ranking EBITDA Margins Lowest Ranking EBITDA Margins
Profitability for Industry's Suppliers Industry Net Cash Flow Margin

Biotechnology & Drugs Industry Operating Margin Statistics

 
Operating Margin Comment
Biotechnology & Drugs Industry increased Operating Margin through reduction in operating costs and despite contraction in Operating Profit by 2.05 % and Revenue 26.39 %. Operating Margin in 1 Q 2017 was 30.56 %, higher than Industry average.

On the trailing twelve months basis operating margin in 1 Q 2017 fell to 31.67 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest operating margin. Operating margin total ranking has deteriorated compare to previous quarter from to 8.

Operating Margin Statistics
High Average Low
38.15 % 21.21 % -56.92 %
1. quarter 2015   2. quarter 2016
You need to upgrade your Flash Player
Operating Margin Industry Ranking
Within: No.
Healthcare Sector # 1
Overall # 8

Biotechnology & Drugs Industry Pre-Tax Margin Statistics

 
You need to upgrade your Flash Player
Pre-Tax Margin Industry Ranking
Within: No.
Healthcare Sector # 2
Overall # 16
Pre-Tax Margin Statistics
High Average Low
35.59 % 19.85 % -49.41 %
2. quarter 2014   2. quarter 2016

Pre-Tax Margin Comment
Biotechnology & Drugs Industry's Revenue increased sequentially by 26.39 % faster than Pre-Tax Income increase of -15.33 %, this led to contraction in Pre-Tax Margin to 19.46 %, below Industry average.

On the trailing twelve months basis Pre-Tax Margin in 1 Q 2017 fell to 26.27 %.

Within Healthcare sector only one Industry has achieved higher Pre-Tax Margin. Pre-Tax Margin total ranking has deteriorated compare to previous quarter from to 16.

Pre-Tax Margins
Compare Industry's pre-tax margin to Chscl's or S&P Net profits within Biotechnology & Drugs Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Chscl's Competitors Industry Tax Rate

Biotechnology & Drugs Industry Net Margin Statistics

 
Net Margin Comment
Biotechnology & Drugs Industry's Revenue increased sequentially by 26.39 % faster than Net Profit increase of -15.33 %, this led to contraction in Net Margin to 14.07 %, below Industry average.

On the trailing twelve months basis Net margin in 1 Q 2017 fell to 35.09 %.

Within Healthcare sector only one Industry has achieved higher Net margin. Net margin total ranking has deteriorated compare to previous quarter from to 17.

Net Margin Statistics
High Average Low
29.14 % 14.55 % -52.05 %
2. quarter 2014   2. quarter 2016
You need to upgrade your Flash Player
Net Margin Industry Ranking
Within: No.
Healthcare Sector # 2
Overall # 17

Other Net Margins
Compare Industry's net margin to Chscl's or S&P Net profits within Biotechnology & Drugs Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Chscl's Suppliers Definiton of Net Margin



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com